Diagnosis and Management of Severe Dry Eyes in Steven Johnson Syndrome Patients

Authors

  • Aulia Nur Fitriatsani University of Lampung
  • Putu Ristyaning Ayu Sangging Universitas Lampung
  • Rani Himayani Universitas Lampung

DOI:

https://doi.org/10.53089/medula.v13i4.1.695

Abstract

Severe dry eyes or what can be called as severe dry eyes is a disease that is often encountered and could be happen to anyone. This disease is a multifactorial disease and is more common in women than men. Risk factors that can cause dry eyes are classified into several categories, namely individuals, environment, chronic disease, autoimmune disease, drugs, and history of injury. One of the factors that causes dry eyes, namely the use of drugs both topical and systemic drugs. The use of five or more drugs simultaneously can increase the risk of dry eyes. One disease that can trigger severe dry eyes in Steven Johnson Syndrome (SJS). SJS is a form of skin and mucous membrane disease caused by the body’s hypersensitivity reaction to a drug or infection. After the damage caused by the acute stage begins to subside, there will be severe visual disturbances and severe dry eyes. In the acute stage, ocular complications occur in 77% of SJS patients. Severe dry eyes can reduce the patient’s quality of life because it can interfere with vision, especially during daily activities. Severe dry eyes in SJS patients involve three important mechanisms, namely tear deficiency, decrease corneal surface moisture, and increase evaporation processes. Treatment of dry eyes can be given with artificial tears and stop using drugs that trigger dry eyes or replace drugs with other drugs. It is important to suppress chronic inflammation of the ocular surface and 2% rebamipide opthalmic solution can help restore stability to the ocular surface.. contact lenses can also be used to improve the patient’s visual acuity and reduce the symptoms associated with severe dry eyes.

References

Rouen, P. A., & White, M. L. Dry Eye Disease: Prevalence, Assessment, and Management. Home Healthcare Now, 2018;36(2).

Messmer, E. M. Pathophysiology, diagnosis and treatment of dry eye. Deutsches Arzteblatt International, 2015;112(5), 71–82.

Elvira, & Wijaya, V. N. Penyakit Mata Kering. CDK Edisi Suplemen, 2018;192–196.

Gomes, J. A. P., Azar, D. T., Baudouin, C., Efron, N., Hirayama, M., Horwath-Winter, J., … Wolffsohn, J. S. TFOS DEWS II iatrogenic report. Ocular Surface, 2017;15(3), 511–538.

Askeroglu, U., Alleyne, B., & Guyuron, B. Pharmaceutical and herbal products that may contribute to dry eyes. Plastic and Reconstructive Surgery, 2013;131(1), 159–167.

Foster, C. S. Dry Eye Disease (Keratoconjunctivitis Sicca). 2019.

Fraunfelder, F. T., Sciubba, J. J., & Mathers, W. D. The Role of Medications in Causing Dry Eye. Journal of Ophthalmology, 2012(August).

Rathi, V. M., & Sangwan, V. S. Prevention, diagnosis & management of dry eye in South Asia. Community eye health, 2017;30(99),S3–S4.

Sotozono, C., Ueta, M., & Yokoi, N. Severe Dry Eye With Combined Mechanisms is Involved in the Ocular Sequelae of SJS/TEN at the Chronic Stage. Investigative Ophthalmology & Visual Science. 2018;59(14).

Metcalfe, D., Iqbal, O., Chodosh, J., Bouchard, C.S., & Saeed, H.N. Acute and Chronic Management of Ocular Disease in Steven Johnson Syndrome/Toxic Epidermal Necrolysis in the USA. Frontiers in Medicine. 2021;8.

Karsenda, Y. Pemberian Kortikosteroid Pada Pasien Sindrom Steven-Johnson. Medula. 2013;1(3);92—100.

Published

2023-06-02

How to Cite

Fitriatsani, A. N., Sangging, P. R. A., & Himayani, R. . (2023). Diagnosis and Management of Severe Dry Eyes in Steven Johnson Syndrome Patients. Medical Profession Journal of Lampung, 13(4.1), 160-165. https://doi.org/10.53089/medula.v13i4.1.695

Most read articles by the same author(s)

1 2 3 4 5 6 7 > >>